An expert discusses how vitiligo treatment historically relied on off-label therapies such as topical corticosteroids, calcineurin inhibitors, and phototherapy, but now includes the first FDA-approved ...

International audience surveys from last year’s menopause documentary, The (M) Factor, shed light on the ongoing need for ...

The authors of an opinion piece in The Lancet Psychiatry make a case for paying more attention to the autistic features of ...

Veena Joy, the U.S. autoimmunity lead for medical and scientific affairs at Thermo Fisher Scientific, discusses the latest in ...

Pavblu, an Eylea biosimilar, shows stable vision outcomes and minimal side effects in real-world use, promising a reliable ...

In a video interview with MHE editors, Brian Anderson, MBA, a principal and consulting actuary at Milliman, shared his entry into the pharmacy benefits space was driven by a desire to improve ...